BioSpace News Archive

Policy

CHMP Grants Positive Opinion for Expanded Use of Darzalex®▼ (daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone (VTd) for Patients with Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible

If approved by the European Commission, the daratumumab-VTd regimen would represent the first therapeutic option indicated for newly diagnosed patients who are eligible for a stem cell transplant in six years

December 16, 2019
·
13 min read
Helsinn to present a scientific poster on acute care use following CINV prophylaxis with agents in breast cancer patients at the San Antonio Breast Cancer Symposium (SABCS) 2019

Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, is presenting a scientific poster assessing acute care involving chemotherapy-induced nausea and vomiting amongst breast cancer patients receiving various treatments for CINV prophylaxis including NEPA, at the San Antonio Breast Cancer Symposium.

December 16, 2019
·
5 min read
Deals

AELIS FARMA raises €11 million to accelerate the clinical development of a paradigm-shifting new class of drugs for treating cannabis addiction and cognitive disorders

AELIS FARMA, a biotechnology company specialized in the treatment of brain disorders, announces the completion of a €11 million financing round from the Region Nouvelle Aquitaine, Inserm Transfert Initiative, Bpifrance and the ACI, NACO and Aelis Innovation regional funds.

December 16, 2019
·
5 min read
Pharm Country

PM360 Lists TrialScope Engage™ Embedded Among Most Innovative Healthcare Products of 2019

Technology integrates a robust clinical trial search function into a sponsor’s existing website

December 16, 2019
·
3 min read
Biocair shortlisted for Global Environmental and Sustainability Award: ‘Unique in the industry’

Global specialist in life sciences logistics, Biocair, has been nominated for an environmental sustainability award.

December 16, 2019
·
1 min read